Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.00
Bid: 20.00
Ask: 22.00
Change: 0.00 (0.00%)
Spread: 2.00 (10.00%)
Open: 21.00
High: 21.00
Low: 21.00
Prev. Close: 21.00
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 2018 Update

10 Oct 2018 07:00

RNS Number : 4852D
Iofina PLC
10 October 2018
 
 

 

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

 

Q3 2018 Update

Record Quarterly Iodine Production Since Company Inception

 

Iofina, specialists in the exploration and production of iodine and halogen-based specialty chemical derivatives, today provides an update to the market regarding its activities during the third quarter ("Q3" or the "Period") of 2018.

 

During the Period, the Company produced the largest quarterly total of crystalline iodine in the history of the organisation, producing a total of 172.3 metric tonnes ("MT") of crystalline iodine from its four operating IOsorb® plants in Oklahoma. This was an increase of 37.8 per cent from the prior year (Q3 2017: 125 MT). This record production reflected a full quarter of strong performance at the new IO#7 plant, as well as continued consistent operation of our mature IOsorb® plants.

 

The Directors anticipate that this positive momentum will continue as the Company moves into the fourth quarter and the winter months. The Directors also remain confident that the Company will achieve the 2018 forecast total of 575-605 MT of crystalline iodine. Iofina's current total of 436.4 MT of produced crystalline iodine through September positions the Company well to significantly surpass 2017 totals (FY 2017: 503 MT). 

 

Commenting, President and CEO Dr. Tom Becker, stated: 

"I am proud of the record quarterly production that has been achieved in the history of Iofina, in the third quarter this year. The execution of the Company's growth strategy, in particular the advantageous location of IO#7, and the performance of the operations team, continues to pay off for the Company and its stakeholders.

 

"Iofina Chemical continues to trade well and is exploring additional revenue streams. Not only have we been marketing the Company's IOflo® crystalline iodine, but also its other chemical products.

 

"As recently stated in our interim results, announced on 20th September 2018, production and profitability continue to move in a positive direction. Debt restructure and growth in 2019 remain the top priority for myself and the management team as we move towards the end of 2018. We expect the positive momentum we are currently achieving to significantly increase the Group's revenues and profits versus the first half of this year."

 

Enquiries:

 

Iofina plc

Dr. Tom Becker, CEO & President

Tel: +44 (0)20 3006 3135

www.iofina.com

 

finnCap Ltd

Christopher Raggett/Anthony Adams/Camille Gochez

Tel: +44 (0)20 7220 0500

 

Media Contact:

Yellow Jersey

Charles Goodwin/Harriet Jackson

Tel: +44 (0)7544 275 882

 About Iofina:

Iofina specialises in the exploration and production of iodine, halogen based specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America, based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Kentucky and Oklahoma. It is a vertically integrated company, covering the process from the production of iodine in the field, to the manufacture of the chemical end-products derived from iodine, supplying them to the consumer, and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilises its portfolio of patented and patent-pending technology, and proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDKLFBVBFLFBV
Date   Source Headline
14th Apr 20107:00 amRNSThird Party Iodine Agreement Signed
22nd Mar 20108:36 amRNSFirst Third Party Iodine Extraction and Collection
22nd Mar 20107:00 amRNSRe Iodine Extraction and Collection Agreement
8th Mar 20107:02 amRNSOperations Update
8th Mar 20107:00 amRNSManagement changes
12th Jan 20103:09 pmRNSDirectorate Change
8th Jan 20107:00 amRNSDirector's Dealings
11th Dec 20096:00 pmRNSHolding in Company
22nd Oct 20095:14 pmRNSChange of Name of Nominated Adviser
19th Oct 20094:07 pmRNSExercise of Options
30th Sep 20097:00 amRNSHalf Yearly Report
10th Aug 200911:13 amRNSManagement Appointments
27th Jul 20097:00 amRNSAcquisition and Operations Update
23rd Jun 200910:20 amRNSResult of AGM
22nd Jun 20094:40 pmRNSSecond Price Monitoring Extn
22nd Jun 20094:35 pmRNSPrice Monitoring Extension
27th May 20094:19 pmRNSPosting of Annual Report
12th May 20097:00 amRNSFinal Results
25th Feb 20099:57 amRNSHolding(s) in Company
23rd Feb 20091:55 pmRNSHolding(s) in Company
19th Feb 200911:06 amRNSDirector/PDMR Shareholding
12th Feb 20094:44 pmRNSPlacing
13th Jan 20097:00 amRNSDirectorate Change
13th Jan 20097:00 amRNSDrilling Update
19th Dec 20085:00 pmRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSOperational Update
7th Nov 20089:59 amRNSHolding(s) in Company
31st Oct 200810:53 amRNSDirector/PDMR Shareholding
30th Oct 20083:39 pmRNSHolding(s) in Company
16th Sep 20085:26 pmRNSDirector/PDMR Shareholding
16th Sep 20084:28 pmRNSDirector/PDMR Shareholding
12th Sep 20085:03 pmRNSDirectorate Change
9th Sep 20087:00 amRNSAppointment of Non Executive
9th Sep 20087:00 amRNSInterim Results
13th Aug 20087:00 amRNSAcquisition
25th Jul 20085:10 pmRNSHolding(s) in Company
16th Jul 20087:00 amRNSOperations Update
10th Jun 20081:29 pmBUSRule 8.3 - INFORMA PLC
9th May 20087:00 amRNSPlacing and Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.